Oklahoma 2022 Regular Session

Oklahoma Senate Bill SB888 Compare Versions

OldNewDifferences
11
22
3-Req. No. 3952 Page 1 1
3+ENGR. H. A. to ENGR. S. B. NO. 888 Page 1 1
44 2
55 3
66 4
77 5
88 6
99 7
1010 8
1111 9
1212 10
1313 11
1414 12
1515 13
1616 14
1717 15
1818 16
1919 17
2020 18
2121 19
2222 20
2323 21
2424 22
2525 23
2626 24
2727
28-STATE OF OKLAHOMA
29-
30-2nd Session of the 58th Legislature (2022)
31-
32-CONFERENCE COMMITTEE SUBSTITUTE
33-FOR ENGROSSED
34-SENATE BILL 888 By: Standridge of the Senate
28+ENGROSSED HOUSE AMENDME NT
29+ TO
30+ENGROSSED SENATE BILL NO . 888 By: Standridge of the Senate
3531
3632 and
3733
38- Marti of the House
34+ Echols of the House
3935
4036
4137
4238
4339
44-CONFERENCE COMMITTEE SUBSTITUTE
45-
4640 An Act relating to controlled dangerous substances;
47-amending 63 O.S. 2021, Section 2 -309, as last amended
48-by Section 1, Chapter 259, O.S .L. 2021, which relates
49-to electronic prescriptions; clarifying certain
50-exception; amending 63 O.S. 2021, Section 2-309D, as
51-last amended by Section 2 of Enrolled Senate Bill No.
52-1151 of the 2nd Session of the 58th Oklahoma
53-Legislature, which relates to the central repository;
54-requiring Oklahoma State Bureau of Narcotics and
55-Dangerous Drugs Control to make certain determination
56-upon certain notification; authorizing Bureau to
57-report certain information to practitioner licensing
58-boards; requiring certain health care providers and
59-employers to carry specified malpractice insurance;
6041 defining terms; requiring pain management clinics to
61-register with the Bureau; providing exemptions;
62-stipulating registration procedures; requiring
63-clinics to designate owner or administrat or
64-responsible for certain compliance ; directing denial
65-of registration for specified reasons ; limiting
42+register with State Board of Medical Licensure and
43+Supervision; providing exemptions; stipulating
44+registration procedures; requiring clinics to
45+designate physician; stipulating procedures for
46+revocation and suspension of registration; limiting
6647 period of suspension; requiring new r egistration
6748 application if clinic changes ownership; specifying
68-responsibilities of licensed prescriber and
69-designated administrator ; providing facility and
49+physician responsibilities; providing facility and
7050 physical operations requiremen ts; stipulating certain
71-infection control requirements; providing certain
72-quality assurance requirements; stipulating certain
73-data collection and reporting requirements; requiring
74-establishment of certain written policy; directing
51+infection control requirements; providing health and
52+safety requirements; providing certain quality
53+assurance requirements; stipulating certain data
54+collection and reporting requirements; providing that
55+designated physician is respo nsible for ensuring
56+compliance with all requirements; providing
57+penalties; directing promulgation of rules; amending
58+59 O.S. 2011, Section 355.1, as amended by Section
59+21, Chapter 230, O.S.L. 2015 (59 O.S. Supp. 2020,
60+Section 355.1), which relates to dispe nsation of
61+dangerous drugs; provi ding certain limitations on
62+dispensation of controlled dangerous substances;
63+providing exception; providing for codification; and
64+providing an effective date.
7565
76-Req. No. 3952 Page 2 1
66+AUTHORS: Remove Echols as principal House author and
67+substitute with Marti
68+
69+
70+AMENDMENT NO. 1. Strike the title, enacting clause, and entire bill
71+and insert:
72+
73+
74+
75+
76+ENGR. H. A. to ENGR. S. B. NO. 888 Page 2 1
7777 2
7878 3
7979 4
8080 5
8181 6
8282 7
8383 8
8484 9
8585 10
8686 11
8787 12
8888 13
8989 14
9090 15
9191 16
9292 17
9393 18
9494 19
9595 20
9696 21
9797 22
9898 23
9999 24
100100
101-certain investigation by Bureau; providing penalties;
102-directing promulgation of rules; providing certain
103-construction; amending 63 O.S. 2021, Section 942 ,
104-which relates to medical examiner reports; requiring
105-Chief Medical Examiner to furnish certain reports to
106-the Bureau; providing for codification; and providing
107-an effective date.
101+"[ controlled dangerous substances - requiring pain
102+management clinics to register wit h State Board of
103+Medical Licensure and Supervision - requiring
104+facility operations to cease when registration is
105+revoked or suspended - prohibiting physicians from
106+practicing medicine in unregistered pain
107+management clinics - effective date ]
108+
108109
109110
110111
111112 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
112-SECTION 1. AMENDATORY 63 O.S . 2021, Section 2-309, as
113-last amended by Section 1, Chapter 259, O. S.L. 2021, is amended to
114-read as follows:
115-Section 2-309. A. 1. Except for dosages medically require d
116-for a period not to exceed forty -eight (48) hours which are
117-administered by or on di rection of a practitioner, other than a
118-pharmacist, or medication dispensed directly by a pract itioner,
119-other than a pharmacist, to an ultimate u ser, no controlled
120-dangerous substance included in Schedule II, which is a prescription
121-drug as determined unde r regulation promulgated by the Board o f
122-Pharmacy, shall be dispensed without an electronic pre scription of a
123-practitioner; provided, that in eme rgency situations, as pre scribed
124-by the Board of Pharmacy by regulation, such drug may be dispensed
125-upon oral prescription reduced promptly to writing and filed by the
126-pharmacist in a manner to be prescribe d by rules and regulations of
127-the Director of the Oklahoma State Bureau of Narcotics and Dangerous
128-Drugs Control.
113+SECTION 1. NEW LAW A new section of law to be codified
114+in the Oklahoma Statutes as Section 2 -1101 of Title 63, un less there
115+is created a duplication in numbering, reads as follows:
116+As used in this act:
117+1. "Board eligible" means successful completion of an
118+anesthesia, physical medicine and rehabilitation, rheumatology or
119+neurology residency program approved by the Ac creditation Council
120+for Graduate Medical Education or the American O steopathic
121+Association for a period of six (6) years from successful completion
122+of such residency program;
123+2. "Chronic nonmalignant pain" means pain unrelated to cancer
124+which persists beyond the usual course of disease or the injury that
125+is the cause of the pain or more than ninety (90) calendar days
126+after surgery; and
129127
130-Req. No. 3952 Page 3 1
128+ENGR. H. A. to ENGR. S. B. NO. 888 Page 3 1
131129 2
132130 3
133131 4
134132 5
135133 6
136134 7
137135 8
138136 9
139137 10
140138 11
141139 12
142140 13
143141 14
144142 15
145143 16
146144 17
147145 18
148146 19
149147 20
150148 21
151149 22
152150 23
153151 24
154152
155-2. Electronic prescrib ing shall be utilized fo r Schedules II,
156-III, IV and V, subject to the requirements set forth in 21 CFR,
157-Section 1311 et seq.
158-3. An electronic prescription with electron ic signature may
159-serve as an original prescription, subject to the requirements set
160-forth in 21 CFR, Section 13 11 et seq.
161-4. Prescriptions shall be r etained in conformity with the
162-requirements of this sect ion and Section 2-307 of this title. No
163-prescription for a Schedule II sub stance may be refilled.
164-5. The electronic prescription requir ement provided for in th is
165-section shall not apply to prescript ions for controlled dangerous
166-substances issued by any o f the following:
167-a. a person licensed to practice veterinary medicine,
168-b. a practitioner who experiences temporary technological
169-or electrical failure or other e xtenuating
170-circumstance that prevents t he prescription from being
171-transmitted electronically; p rovided, however, that
172-the practitioner documents the reason for this
173-exception in the medical record of the patient,
174-c. a practitioner, other than a pharmacist, who dispenses
175-directly to an ultimate user,
176-d. a practitioner who orders a controlled dangerou s
177-substance to be administered through an on -site
178-pharmacy in:
153+3. "Pain management clinic" or "clinic" means any publicly or
154+privately owned facility:
155+a. that advertises in any medium for any type of pain
156+management services, and
157+b. where in any month a majority of patients are
158+prescribed opioids, benzodiazepines, barbiturates or
159+carisoprodol for the treatment of chronic nonmalignant
160+pain.
161+SECTION 2. NEW LAW A ne w section of law to be codified
162+in the Oklahoma Statutes as Section 2-1102 of Title 63, unless there
163+is created a duplication in numbering, reads as follows:
164+A. Each pain management clinic shall register with the State
165+Board of Medical Licensure and Super vision unless:
166+1. The majority of the physicians who provide servic es in the
167+clinic primarily provide surgical services;
168+2. The clinic is affiliated with an accredited medical school
169+at which training is provided for medical students, residents or
170+fellows;
171+3. The clinic does not prescribe controlled dangerous
172+substances for the treatment of pain;
173+4. The clinic is wholly owned and operated by one or more
174+board-eligible or board-certified anesthesiologists, physiatrists,
175+rheumatologists or neurologists; o r
179176
180-Req. No. 3952 Page 4 1
177+ENGR. H. A. to ENGR. S. B. NO. 888 Page 4 1
181178 2
182179 3
183180 4
184181 5
185182 6
186183 7
187184 8
188185 9
189186 10
190187 11
191188 12
192189 13
193190 14
194191 15
195192 16
196193 17
197194 18
198195 19
199196 20
200197 21
201198 22
202199 23
203200 24
204201
205-(1) a hospital as defined in Section 1-701 of this
206-title,
207-(2) a nursing facility as defined in Sec tion 1-1902
208-of this title,
209-(3) a hospice inpatient facility as defined in
210-Section 1-860.2 of this title,
211-(4) an outpatient dialysis facility,
212-(5) a continuum of care faci lity as defined in
213-Section 1-890.2 of this title, or
214-(6) a penal institution listed in Section 509 of
215-Title 57 of the Oklahom a Statutes,
216-e. a practitioner who orders a controlled da ngerous
217-substance to be administered through a hos pice program
218-as defined in Section 1-860.2 of this title including
219-but not limited to a hospice program tha t provides
220-outpatient services,
221-f. a practitioner who writes a prescription to be
222-dispensed by a pharmacy located on federal property,
223-provided the practitioner documents the reason for
224-this exception in the medical record of the patient,
225-or
226-g. a practitioner that has received a waiver or extension
227-from his or her licensing board.
202+5. The clinic is wholly owned and operated by a physician
203+multispecialty practice where one or more board -eligible or board-
204+certified medical specialists, who have also completed fellowships
205+in pain medicine approved by the Accreditation Council for Gra duate
206+Medical Education or who are also certified in pain medicine b y the
207+American Board of Pain Medicine or a board approved by the American
208+Board of Physician Specialties, the American Association of
209+Physician Specialists or the American Osteopathic Asso ciation,
210+perform interventional pain procedures of the type routinel y billed
211+using surgical codes.
212+B. Each clinic location shall be registered separately
213+regardless of whether the clinic is operated under the same business
214+name or management as another cl inic.
215+C. As a part of registration, a clinic shall designate a
216+physician who is responsible for complying with all requirements
217+related to registration and operation of the clinic in compliance
218+with this act. Within ten (10) calendar days after terminati on of a
219+designated physician, the clinic shall notify the State Boar d of
220+Medical Licensure and Supervision of the identity of another
221+designated physician for that clinic. The designated physician
222+shall have a full, active and unencumbered license pursuan t to
223+Section 480 et seq. or Section 620 et seq. of Title 59 of the
224+Oklahoma Statutes and shall practice at the clinic location for
225+which the physician has assumed responsibility. Failing to have a
228226
229-Req. No. 3952 Page 5 1
227+ENGR. H. A. to ENGR. S. B. NO. 888 Page 5 1
230228 2
231229 3
232230 4
233231 5
234232 6
235233 7
236234 8
237235 9
238236 10
239237 11
240238 12
241239 13
242240 14
243241 15
244242 16
245243 17
246244 18
247245 19
248246 20
249247 21
250248 22
251249 23
252250 24
253251
254-6. Electronic prescri ptions shall not be utilized under the
255-following circumstances:
256-a. compound prescriptions containing two or more
257-commercially available products or two or more a ctive
258-pharmaceutical ingredients,
259-b. compounded infusion prescriptions containing two or
260-more commercially available products or two or more
261-active pharmaceutical ingredi ents,
262-c. prescriptions issued under approved research
263-protocols, or
264-d. if the practitioner determines that an electronic
265-prescription cannot be issued in a timely manner and
266-the condition of the patient is at risk.
267-7. A pharmacist who receives a written, oral or facsimile
268-prescription shall not be required to verify that the prescription
269-falls under one of the exceptions provid ed for in paragraph 6 of
270-this subsection. Pharmacists m ay continue to dispense medications
271-from otherwise valid written, oral or f acsimile prescriptions that
272-are consistent with the provisions of this section.
273-8. Practitioners shall indicate in the healt h record of a
274-patient that an exception to the electroni c prescription requirement
275-was utilized.
276-9. All prescriptions issued pursu ant to paragraphs 5 and 6 of
277-this subsection shall be issued on an official prescripti on form
252+licensed designated physician practicing at the location o f the
253+registered clinic may be the basis for a summary suspension of the
254+clinic registration certificate as described in this section.
255+D. The State Board of Medical Licensure and Supervision shall
256+deny registration to any pain management clinic owned by o r with any
257+contractual or employment relationship with a physician:
258+1. Whose Drug Enforcement Administration number has ever been
259+revoked;
260+2. Whose application for a license to prescribe, dispense or
261+administer a controlled substance has been denied for disciplinary
262+action by the appropriate medical regulatory board of t he physician;
263+or
264+3. Who has been convicted of or pleaded guilty or nolo
265+contendere to, regardless of adjudication, an offense that
266+constitutes a felony for receipt of illicit or diverted drugs,
267+including a controlled substance listed in Schedule I, II, II I, IV
268+or V of the Uniform Controlled Dangerous Substances Act, in this
269+state, any other state or the United States.
270+E. If the State Board of Medical Licensure and Supervision
271+finds that a pain management clinic is owned, directly or
272+indirectly, by a perso n meeting any criteria listed in subsection D
273+of this section, the State Board of Medical Licensure and
274+Supervision shall revoke the certificate of registration previously
275+issued by the State Board of Medical Licensure and Supervision. As
278276
279-Req. No. 3952 Page 6 1
277+ENGR. H. A. to ENGR. S. B. NO. 888 Page 6 1
280278 2
281279 3
282280 4
283281 5
284282 6
285283 7
286284 8
287285 9
288286 10
289287 11
290288 12
291289 13
292290 14
293291 15
294292 16
295293 17
296294 18
297295 19
298296 20
299297 21
300298 22
301299 23
302300 24
303301
304-provided by the Oklahoma State Bureau of Narcotics and Dangerous
305-Drugs Control.
306-10. a. Effective January 1, 2020, practitioners shall
307-register with the Oklahoma S tate Bureau of Narcotics
308-and Dangerous Drugs Control in order to be issued
309-official prescription forms. Such registration sh all
310-include, but not be limited to, the primary address
311-and the address of each place of business to be
312-imprinted on official presc ription forms. Any change
313-to a registered practitioner 's registered address
314-shall be promptly reported to the practitioner 's
315-licensing board and the Bureau by the practitioner in
316-a manner approved by the Bureau.
317-b. A practitioner's registration shall be w ithout fee and
318-subject to approval by the Bureau. Such registration
319-shall be valid for a period of two (2) years and may
320-be denied, suspended or revoked by the Bureau upon a
321-finding by the Bureau or licensing board that the
322-registered practitioner has had any license to
323-practice a medical profession revoked or suspended by
324-any state or federal agency.
325-c. Where the Bureau has re voked the registration of a
326-registered practitioner, the Bureau may revoke or
327-cancel any official prescrip tion forms in the
302+determined by rule, the State Board of Medical Licensure and
303+Supervision may grant an exemption to denying a registration or
304+revoking a previously issued registration if more than five (5)
305+years have elapsed since adjudication. As used in this section, the
306+term "convicted" includes an adjudication of guilt following a plea
307+of guilty or nolo contendere or the forfeiture of a bond when
308+charged with a crime.
309+F. If the registration of a pain management clini c is revoked
310+or suspended, the designated physician of the pain mana gement
311+clinic, the owner or lessor of the pain management clinic property,
312+the manager and the proprietor shall cease to operate the facility
313+as a pain management clinic as of the effectiv e date of the
314+suspension or revocation.
315+G. If a pain management cli nic registration is revoked or
316+suspended, the designated physician of the pain management clinic,
317+the owner or lessor of the clinic property, the manager or the
318+proprietor is responsible f or removing all signs and symbols
319+identifying the premises as a pain management clinic.
320+H. If the clinic’s registration is revoked, any person named in
321+the registration documents of the pain management clinic, including
322+persons owning or operating the pai n management clinic, shall not,
323+as an individual or as a part of a g roup, apply to operate a pain
324+management clinic for one (1) year after the date the registration
325+is revoked.
328326
329-Req. No. 3952 Page 7 1
327+ENGR. H. A. to ENGR. S. B. NO. 888 Page 7 1
330328 2
331329 3
332330 4
333331 5
334332 6
335333 7
336334 8
337335 9
338336 10
339337 11
340338 12
341339 13
342340 14
343341 15
344342 16
345343 17
346344 18
347345 19
348346 20
349347 21
350348 22
351349 23
352350 24
353351
354-possession of the registered practitioner. Any
355-revocation or any suspension shall require th e
356-registered practitioner to return all unused official
357-prescription forms to the Bureau within fifteen (15)
358-calendar days after the date of the written
359-notification.
360-d. A practitioner that has had any license to practice
361-terminated, revoked or suspended b y a state or federal
362-agency may, upon restoration of such license or
363-certificate, register to b e issued official
364-prescription forms.
365-11. a. Except as provided in subparag raph f of this
366-paragraph, the Bureau shall issue official
367-prescription forms free of c harge only to registered
368-practitioners in this state. Such forms shall not be
369-transferable. The number of official prescription
370-forms issued to a registered practitione r at any time
371-shall be at the discretion of the Bureau.
372-b. Official prescription forms issued to a registered
373-practitioner shall be imprinted only with the primary
374-address and other addresses listed on the registration
375-of the practitioner. Such prescripti ons shall be sent
376-only to the primary address of the registered
377-practitioner.
352+I. The period of suspension for the registration of a pain
353+management clinic shall be prescribed by the State Board of Medical
354+Licensure and Supervision but shall not exceed one (1) year.
355+J. A change of ownership of a registered pain management clinic
356+requires submission of a new registration application.
357+SECTION 3. NEW LAW A new section of law to be codified
358+in the Oklahoma Statutes as Section 2-1103 of Title 63, unless there
359+is created a duplication in numbering, reads as follows:
360+A. A physician shall not practice medicine in a pain management
361+clinic if the clinic is not registered with the State Board of
362+Medical Licensure and Supervision as required by this act. Any
363+physician who qualifies to practice medicine in a pain management
364+clinic pursuant to rules adopted by the appropriate medical
365+regulatory board of the physician may continue to practice medicine
366+in a pain management clinic as long as the physician continues to
367+meet the qualifications prescribed in the rules. A physician who
368+violates this subsection is subject to disciplinary action by the
369+appropriate medical regulatory board of the physician.
370+B. Only a physician licensed pursuant to Section 480 et seq. or
371+Section 620 et seq. of Title 59 of the Oklahoma Statutes may
372+prescribe a controlled dangerous substance on the premises of a
373+registered pain management clinic. No person shall dispense any
374+controlled dangerous substance on the premises of a pain management
375+clinic.
378376
379-Req. No. 3952 Page 8 1
377+ENGR. H. A. to ENGR. S. B. NO. 888 Page 8 1
380378 2
381379 3
382380 4
383381 5
384382 6
385383 7
386384 8
387385 9
388386 10
389387 11
390388 12
391389 13
392390 14
393391 15
394392 16
395393 17
396394 18
397395 19
398396 20
399397 21
400398 22
401399 23
402400 24
403401
404-c. Official prescription forms issued to a regi stered
405-practitioner shall be used only by the practition er to
406-whom they are issued.
407-d. The Bureau may revoke or cancel official pre scription
408-forms in possession of registered practitioners when
409-the license of such pra ctitioner is suspended,
410-terminated or revoked.
411-e. Official prescription forms of registered
412-practitioners who are deceased or who no longer
413-prescribe shall be returned to the Bureau at a
414-designated address. If the registered practitioner is
415-deceased, it is the responsibility of the registered
416-practitioner's estate or lawful designee to return
417-such forms.
418-f. The Bureau may issue official prescripti on forms to
419-employees or agents of the Bureau and other government
420-agencies for the purpose of preventing, iden tifying,
421-investigating and prosecuting unacceptable or illegal
422-practices by providers and other persons and assisting
423-in the recovery of overpaym ents under any program
424-operated by the state or paid for with state funds.
425-Such prescription forms shall be is sued for this
426-purpose only to individua ls who are authorized to
427-conduct investigations on behal f of the Bureau or
402+C. A physician, a physician assistant or an Advanced Practice
403+Registered Nurse shall perform a physical examination of a patient
404+on the same day that the physician prescribes a controlled substance
405+to a patient at a pain management clinic.
406+D. A physician authorized to prescribe controlled dangerous
407+substances who practices at a pain management clinic is responsible
408+for maintaining the control and security of his or her prescription
409+blanks and any other method used for prescribing controlled
410+dangerous substance pain medication. The physician shall notify, in
411+writing, the State Board of Medical Licensure and Supervision within
412+twenty-four (24) hours following any theft or loss of a prescription
413+blank or breach of any other method for prescribing pain medication.
414+E. The designated physician of a pain management clinic shall
415+notify the applicable board in writing of the date of termin ation of
416+employment within ten (10) calendar days after terminating his or
417+her employment with a pain management clinic that is required to be
418+registered pursuant to this act. Each physician practicing in a
419+pain management clinic shall advise the State Bo ard of Medical
420+Licensure and Supervision, in writing, within ten (10 ) calendar days
421+after beginning or ending his or her practice at a pain management
422+clinic.
423+F. Each physician practicing in a pain management clinic is
424+responsible for ensuring compliance with the following facility and
425+physical operations requirements:
428426
429-Req. No. 3952 Page 9 1
427+ENGR. H. A. to ENGR. S. B. NO. 888 Page 9 1
430428 2
431429 3
432430 4
433431 5
434432 6
435433 7
436434 8
437435 9
438436 10
439437 11
440438 12
441439 13
442440 14
443441 15
444442 16
445443 17
446444 18
447445 19
448446 20
449447 21
450448 22
451449 23
452450 24
453451
454-other government agencies as pa rt of their official
455-duties. Individuals and agencies receiving such
456-prescription forms for this purpose shall provide
457-appropriate assurances to the Bureau that adequate
458-safeguards and security measures ar e in place to
459-prevent the use of such prescription forms for
460-anything other than official government purposes.
461-12. a. Adequate safeguards and security measures s hall be
462-undertaken by registered practi tioners holding
463-official prescription forms to assure ag ainst the
464-loss, destruction, theft or unauthorized use of the
465-forms. Registered practitioners shall maintain a
466-sufficient but not excessive supply of such forms in
467-reserve.
468-b. Registered practitioner s shall immediately notify the
469-Bureau, in a manner desig nated by the Bureau, upon
470-their knowledge of the l oss, destruction, theft o r
471-unauthorized use of any official prescription forms
472-issued to them, as well as the f ailure to receive
473-official prescription forms within a reasonable time
474-after ordering them from the Bureau.
475-c. Registered practitioners shall imm ediately notify the
476-Bureau upon their knowledge of any diversion or
452+1. A pain management clinic shall be located and operated at a
453+publicly accessible fixed location and shall:
454+a. display a sign that can be viewed by the public that
455+contains the clinic name , hours of operations and a
456+street address,
457+b. have a publicly liste d telephone number and a
458+dedicated phone number to send and receive facsimiles,
459+c. have a reception and waiting area,
460+d. provide a restroom,
461+e. have private patient examination rooms,
462+f. have treatment rooms, if treatment is being provided
463+to the patients, and
464+g. display a printed sign located in a conspicuous place
465+in the waiting room viewable by the public with the
466+name and contact information of the clinic’s
467+designated physician and the names of all physicians
468+practicing in the clinic; and
469+2. This section does not excuse a physician from providing any
470+treatment or performing any medical duty without the proper
471+equipment and materials as required by the standard of care. This
472+section does not supersede the level of care, skill or treatment
473+recognized in general law related to health care licensure.
477474
478-Req. No. 3952 Page 10 1
475+ENGR. H. A. to ENGR. S. B. NO. 888 Page 10 1
479476 2
480477 3
481478 4
482479 5
483480 6
484481 7
485482 8
486483 9
487484 10
488485 11
489486 12
490487 13
491488 14
492489 15
493490 16
494491 17
495492 18
496493 19
497494 20
498495 21
499496 22
500497 23
501498 24
502499
503-suspected diversion of drugs pursuant to th e loss,
504-theft or unauthorized use of pr escriptions.
505-B. 1. Except for dosages medically requir ed for a period not
506-to exceed seventy-two (72) hours which are administered by or on
507-direction of a practitioner, other than a pharmacist, or medication
508-dispensed directly by a practitioner, other tha n a pharmacist, to an
509-ultimate user, no controlled dange rous substance included in
510-Schedule III or IV, whi ch is a prescription drug as determined under
511-regulation promulgated by the Board of Pharmacy, shall be dispens ed
512-without an electronic prescription.
513-2. Any prescription for a controlled dangerous substanc e in
514-Schedule III, IV or V may not be filled or re filled more than six
515-(6) months after the date thereof or be refilled more than five
516-times after the date of th e prescription, unless renewed by the
517-practitioner.
518-C. Whenever it appears to the Director of the Oklahoma State
519-Bureau of Narcotics and Dangero us Drugs Control that a d rug not
520-considered to be a prescription drug under existing state law or
521-regulation of the Board of Pharmacy should be so con sidered because
522-of its abuse potential, the Director sha ll so advise the Board of
523-Pharmacy and furnish to the Board all available d ata relevant
524-thereto.
525-D. 1. "Prescription", as used in this section, means a
526-written, oral or electronic order by a practit ioner to a pharmacist
500+G. Each physician practicing in a pain management clinic is
501+responsible for ensuring compliance with the following infection
502+control requirements:
503+1. The clinic shall maintain equipment and supplies to suppor t
504+infection prevention and control activities;
505+2. The clinic shall identify infection risks based on the
506+following:
507+a. geographic location, community and population served,
508+b. the care, treatment and services it provides, and
509+c. an analysis of its infecti on surveillance and control
510+data; and
511+3. The clinic shall maintain written infection prevention
512+policies and procedures that address the following:
513+a. prioritized risks,
514+b. limiting unprotected exposure to pathogens,
515+c. limiting the transmission of infect ions associated
516+with procedures performed in the clinic, and
517+d. limiting the transmission of infections associated
518+with the clinic’s use of medical equipment, devices
519+and supplies.
520+H. Each physician practicing in a pain management clinic is
521+responsible for ensuring that the clinic, including its grounds,
522+buildings, furniture, appliances and equipment is structurally
527523
528-Req. No. 3952 Page 11 1
524+ENGR. H. A. to ENGR. S. B. NO. 888 Page 11 1
529525 2
530526 3
531527 4
532528 5
533529 6
534530 7
535531 8
536532 9
537533 10
538534 11
539535 12
540536 13
541537 14
542538 15
543539 16
544540 17
545541 18
546542 19
547543 20
548544 21
549545 22
550546 23
551547 24
552548
553-for a controlled dangerous substan ce for a particular patient, which
554-specifies the date of its issue, and the full name and address of
555-the patient and, if the controlled dangerous substance is pr escribed
556-for an animal, the species of the animal, the name and quantity of
557-the controlled dangerous substance prescribed, the directions for
558-use, the name and address of the owner of the animal and, if
559-written, the signature of the practitioner.
560-2. "Registered practitioner", as used in this section, means a
561-licensed practitioner duly registered wi th the Oklahoma State Bureau
562-of Narcotics and Dang erous Drugs Control to be issued official
563-prescription forms.
564-E. No person shall solicit, dispense, receive or deliver any
565-controlled dangerous subst ance through the mail, unless the ultimate
566-user is personally known to the practitioner and circumstances
567-clearly indicate such met hod of delivery is in the best interest of
568-the health and welfare of the ultimate user .
569-SECTION 2. AMENDATORY 63 O.S. 2021, Section 2 -309D, as
570-last amended by Section 2 of Enrolled Senate Bill No. 1151 of the
571-2nd Session of the 58th Oklahoma Legislature , is amended to read as
572-follows:
573-Section 2-309D. A. The information collected at the central
574-repository pursuant to the Anti -Drug Diversion Act shall be
575-confidential and shall not be open to the public. Ac cess to the
576-information shall be limited to:
549+sound, in good repair, clean and free from health and safety
550+hazards.
551+I. The designated physician is responsible for ensuring
552+compliance with the following quality assurance requirements:
553+1. Each pain management clinic shall have an ongoing quality
554+assurance program that objectively and systematically:
555+a. monitors and evaluate s the quality and appropriateness
556+of patient care,
557+b. evaluates methods to improve patient care,
558+c. identifies and corrects deficiencies within the
559+facility,
560+d. alerts the designated physician to identify and
561+resolve recurring problems, and
562+e. provides for opportunities to improve the facility’s
563+performance and to enhance and improve the quality of
564+care provided to the public; and
565+2. The designated physician shall establish a quality assurance
566+program that includes the following components:
567+a. the identification, investigation and analysis of the
568+frequency and causes of ad verse incidents to patients,
569+b. the identification of trends or patterns of incidents,
570+c. the development of measures to correct, reduce,
571+minimize or eliminate the risk of adverse incident s to
572+patients, and
577573
578-Req. No. 3952 Page 12 1
574+ENGR. H. A. to ENGR. S. B. NO. 888 Page 12 1
579575 2
580576 3
581577 4
582578 5
583579 6
584580 7
585581 8
586582 9
587583 10
588584 11
589585 12
590586 13
591587 14
592588 15
593589 16
594590 17
595591 18
596592 19
597593 20
598594 21
599595 22
600596 23
601597 24
602598
603-1. Peace officers certified pursuant to Section 3311 of Title
604-70 of the Oklahoma Statutes who are employed as investigative agents
605-of the Oklahoma State Bureau of Narcotics and Dangerous Drugs
606-Control;
607-2. The United States Drug Enforcement Administration Diversion
608-Group Supervisor;
609-3. The executive director or chief investigator, as designated
610-by each board, of the following state boards:
611-a. Board of Podiatric Medical Examiners,
612-b. Board of Dentistry,
613-c. Board of Pharmacy,
614-d. State Board of Medical Licensure and Supervision,
615-e. State Board of Osteopathic Examiners,
616-f. State Board of Veterinary Medical Examiners,
617-g. Oklahoma Health Care Authority ,
618-h. Department of Mental Health and Substance Abuse
619-Services,
620-i. Board of Examiners in Optometry,
621-j. Oklahoma Board of Nursing,
622-k. Office of the Chief Medical Examiner, and
623-l. State Board of Health;
624-4. A multicounty grand jury properly convened pursuant to the
625-Multicounty Grand Jury Act;
599+d. the documentation of these functions and perio dic
600+review no less than quarterly of such information by
601+the designated physician.
602+J. The designated physician is responsible for ensuring
603+compliance with the following data collection an d reporting
604+requirements:
605+1. The designated physician for each pain management clinic
606+shall report all adverse incidents to the State Board of Medical
607+Licensure and Supervision; and
608+2. The designated physician shall also report to the State
609+Board of Medical Licensure and Supervision, in writing, on a
610+quarterly basis the following data:
611+a. the number of new and repeat patients seen and treated
612+at the clinic who are prescribed controlled dangerous
613+substance medications for the treatment of chronic,
614+nonmalignant pain,
615+b. the number of patients discharged due to drug abuse,
616+c. the number of patients discharged due to drug
617+diversion, and
618+d. the number of patients treated at the clinic whose
619+domicile is located somewhere other than in this
620+state. A patient’s do micile is the patient’s fixed or
621+permanent home to which he or she i ntends to return
626622
627-Req. No. 3952 Page 13 1
623+ENGR. H. A. to ENGR. S. B. NO. 888 Page 13 1
628624 2
629625 3
630626 4
631627 5
632628 6
633629 7
634630 8
635631 9
636632 10
637633 11
638634 12
639635 13
640636 14
641637 15
642638 16
643639 17
644640 18
645641 19
646642 20
647643 21
648644 22
649645 23
650646 24
651647
652-5. Medical practitioners employ ed by the United States
653-Department of Veterans Affairs, the United States Military, or other
654-federal agencies treating patients in this state;
655-6. At the discretion of the Director of the Oklahoma State
656-Bureau of Narcotics and Dangerous Drugs Control, medi cal
657-practitioners and their staff including those employed by the
658-federal government in this state; and
659-7. The members of the Opioid Overdose Fatality Review Board for
660-the purpose of carrying out the duties prescribed by Section 2 -1001
661-of this title.
662-B. This section shall not prevent access, at the discretion of
663-the Director of the Oklahoma State Bureau of Narcotics and Dangerous
664-Drugs Control, to investigative information by peace of ficers and
665-investigative agents of federal, state, tribal, county or mun icipal
666-law enforcement agencies, district attorneys and the Attorney
667-General in furtherance of criminal, civil or administrative
668-investigations or prosecutions within their respective
669-jurisdictions, designat ed legal, communications, and analytical
670-employees of the Bureau, and to registrants in furtherance of
671-efforts to guard against the diversion of controlled dangerous
672-substances.
673-C. This section shall not prevent the disclosure, at t he
674-discretion of the Di rector of the Oklahoma State Bureau of Narcotics
675-and Dangerous Drugs Control, of statistical information gathered
648+even though he or she may temporarily reside
649+elsewhere.
650+K. The data and reports specified in subsection J of this
651+section shall be accessible to the Oklahoma State Bureau of
652+Narcotics and Dangerous Drugs Control.
653+SECTION 4. NEW LAW A new section of law to be codified
654+in the Oklahoma Statutes as Section 2 -1104 of Title 63, unless there
655+is created a duplication in numbering, reads as follows:
656+A. The State Board of Medical Licensure and Supervision may
657+impose an administrative fine on a clinic of up to Five Thousand
658+Dollars ($5,000.00) per violation for violating the requirements of
659+this act or the rules of the State Board of Medical Licensure and
660+Supervision. In determining whether a penalty is to be imposed, and
661+in fixing the amount of the fine, the State Board of Medical
662+Licensure and Supervision shall consider the following factors:
663+1. The gravity of the violation, including the probability that
664+death or serious physical or emotional harm to a patient has
665+resulted, or could have resulted, from the pain management clinic’s
666+actions or the actions of the physician, the severity of the action
667+or potential harm and the extent to which the provisions of the
668+applicable laws or rules were violated;
669+2. What actions, if any , the owner or designated physician took
670+to correct the violations;
676671
677-Req. No. 3952 Page 14 1
672+ENGR. H. A. to ENGR. S. B. NO. 888 Page 14 1
678673 2
679674 3
680675 4
681676 5
682677 6
683678 7
684679 8
685680 9
686681 10
687682 11
688683 12
689684 13
690685 14
691686 15
692687 16
693688 17
694689 18
695690 19
696691 20
697692 21
698693 22
699694 23
700695 24
701696
702-from the central repository to the general public for statistical,
703-research, substance abuse prevention, or educational purposes,
704-provided that consumer confidentiality is not compromised.
705-D. This section shall not prevent the disclosure, at the
706-discretion of the Director of the Oklahoma State Bureau of Narcotics
707-and Dangerous Drugs Control, of prescription -monitoring-program
708-information to prescription-monitoring programs of other states
709-provided a reciprocal data-sharing agreement is in place.
710-E. The Department of Mental Health and Substance Abuse Services
711-and the State Department of Health may utilize the information i n
712-the central repositor y for statistical, research, substance abuse
713-prevention, or educational purposes, provided that consumer
714-confidentiality is not compromised.
715-F. Any unauthorized disclosure of any information collected at
716-the central repository provi ded by the Anti-Drug Diversion Act shall
717-be a misdemeanor. Violation of the provisions of this section shall
718-be deemed willful neglect of duty and shall be grounds for removal
719-from office.
720-G. 1. Registrants shall have access to the central repository
721-for the purposes of patie nt treatment and to aid in the
722-determination in prescribing or screening new patients. The
723-physician or designee shall provide, upon request by the patient,
724-the history of the patient or the query history of the patient.
697+3. Whether there were any previous violations at the pain
698+management clinic; and
699+4. The financial benefits that the pa in management clinic
700+derived from committing or continuing to commit the violation.
701+B. Each day a violation continues after the date fixed for
702+termination of the violation as ordered by the State Board of
703+Medical Licensure and Supervision constitutes an a dditional,
704+separate and distinct violation.
705+C. The State Board of M edical Licensure and Supervision may
706+impose a fine and, in the case of an owner -operated pain management
707+clinic, revoke or deny a pain management clinic’s registration if
708+the clinic’s designated physician knowingly and intentionally
709+misrepresents actions t aken to correct a violation.
710+D. An owner or designated physician of a pain management clinic
711+who concurrently operates an unregistered pain management clinic is
712+subject to an administrati ve fine of Five Thousand Dollars
713+($5,000.00) per day.
714+E. If the owner of a pain management clinic that requires
715+registration fails to apply to register the clinic upon a change of
716+ownership and operates the clinic under the new ownership, the owner
717+is subject to a fine of Five Thousand Dollars ($5,000.00).
718+SECTION 5. NEW LAW A new section of law to be codified
719+in the Oklahoma Statutes as Section 2 -1105 of Title 63, unless there
720+is created a duplication in numbering, reads as follows :
725721
726-Req. No. 3952 Page 15 1
722+ENGR. H. A. to ENGR. S. B. NO. 888 Page 15 1
727723 2
728724 3
729725 4
730726 5
731727 6
732728 7
733729 8
734730 9
735731 10
736732 11
737733 12
738734 13
739735 14
740736 15
741737 16
742738 17
743739 18
744740 19
745741 20
746742 21
747743 22
748744 23
749745 24
750746
751-2. a. Prior to prescribing or auth orizing for refill, if one
752-hundred eighty (180) d ays have elapsed prior to the
753-previous access and check, of opiates, synthetic
754-opiates, semisynthetic opiates, benzodiazepine or
755-carisoprodol to a patient of record, registrants or
756-members of their medical o r administrative staff shall
757-be required to acces s the information in the central
758-repository to assess medical necessity and the
759-possibility that the patient may be unlawfully
760-obtaining prescription drugs in violation of the
761-Uniform Controlled Dangerous Su bstances Act. The duty
762-to access and check shall not alter or otherwise amend
763-appropriate medical standards of care. The registrant
764-or medical provider shall note in the patient file
765-that the central repository has been checked and may
766-maintain a copy of the information.
767-b. The requirements set forth i n subparagraph a of this
768-paragraph shall not apply:
769-(1) to medical practitioners who prescribe the
770-controlled substances set forth in subparagraph a
771-of this paragraph for hospice or en d-of-life
772-care, or
773-(2) for a prescription of a controlled substance set
774-forth in subparagraph a of this paragraph that is
747+All affected agencies and boards shall promulgate such rules as
748+are necessary to implement the provisions of this act.
749+SECTION 6. This act shall become effective November 1, 2021. "
750+Passed the House of Representatives the 28th day of April, 2022.
775751
776-Req. No. 3952 Page 16 1
752+
753+
754+
755+
756+Presiding Officer of the House of
757+ Representatives
758+
759+
760+Passed the Senate the ____ day of _______ ___, 2022.
761+
762+
763+
764+
765+
766+Presiding Officer of the Senate
767+
768+
769+ENGR. S. B. NO. 888 Page 1 1
777770 2
778771 3
779772 4
780773 5
781774 6
782775 7
783776 8
784777 9
785778 10
786779 11
787780 12
788781 13
789782 14
790783 15
791784 16
792785 17
793786 18
794787 19
795788 20
796789 21
797790 22
798791 23
799792 24
800793
801-issued by a practitioner for a patient residing
802-in a nursing facility as defined by Section 1 -
803-1902 of this title, provided that the
804-prescription is issued to a resident of such
805-facility.
806-3. Registrants shall not be liable to any person for any claim
807-of damages as a result of accessing or failing to access the
808-information in the central repository and no lawsuit may be
809-predicated thereon.
810-4. The failure of a registrant to access and check the central
811-repository as required under state or federal law or regulation may,
812-after investigation, be grounds for the licensing board of the
813-registrant to take disciplinary action against the registr ant.
814-H. The Board of Podiatric Medical Examiners, the Board of
815-Dentistry, the State Board of Medical Licensure and Supervision, the
816-Board of Examiners in Optometry, the Oklahoma Board of Nursing, the
817-State Board of Osteopathic Examiners and the State Boar d of
818-Veterinary Medical Examiners shall have the sole responsibility for
819-enforcement of the provisions of subsection G of this section.
820-Nothing in this section shall be construed so as to permit the
821-Director of the State Bureau of Narcotics and Dangerous Drugs
822-Control to assess administrative fines provided for in Section 2 -304
823-of this title.
794+ENGROSSED SENATE
795+BILL NO. 888 By: Standridge of the Senate
824796
825-Req. No. 3952 Page 17 1
797+ and
798+
799+ Echols of the House
800+
801+
802+
803+
804+An Act relating to controlled dangerous substances;
805+defining terms; requiring pain management clinics to
806+register with State Board of Medical Licensure and
807+Supervision; providing exemptions; stipulating
808+registration procedures; requiring clinics to
809+designate physician; stipulating procedures for
810+revocation and suspension of registration; limiting
811+period of suspension; requiring new registration
812+application if clinic changes ownership; specifying
813+physician responsibilities; providing facility and
814+physical operations requirements; stipulating certain
815+infection control requirements; providing health and
816+safety requirements; providing certain quality
817+assurance requirements; stipulating certain data
818+collection and reporting requirements; providing that
819+designated physician is responsible for ensuring
820+compliance with all requirements; providing
821+penalties; directing promulgation of rules; amending
822+59 O.S. 2011, Section 355.1, as amended by Section
823+21, Chapter 230, O.S.L. 2015 (59 O.S. Supp. 2020,
824+Section 355.1), which relates to dispensation of
825+dangerous drugs; provi ding certain limitations on
826+dispensation of controlled dangerous substances;
827+providing exception; providing for codification; and
828+providing an effective date .
829+
830+
831+
832+
833+
834+BE IT ENACTED BY THE PEOPLE OF THE STATE O F OKLAHOMA:
835+SECTION 7. NEW LAW A new section of law to be codi fied
836+in the Oklahoma Statutes as Section 2 -1101 of Title 63, unless there
837+is created a duplication in numbering, reads as follows:
838+
839+ENGR. S. B. NO. 888 Page 2 1
826840 2
827841 3
828842 4
829843 5
830844 6
831845 7
832846 8
833847 9
834848 10
835849 11
836850 12
837851 13
838852 14
839853 15
840854 16
841855 17
842856 18
843857 19
844858 20
845859 21
846860 22
847861 23
848862 24
849863
850-I. The Director of the Oklahoma State Bureau of Narcotics and
851-Dangerous Drugs Control, or a designee thereof, shall provide a
852-monthly list to the Directors of the Board of Podiatric Medica l
853-Examiners, the Board of Dentistry, the State Bo ard of Medical
854-Licensure and Supervision, the Board of Examiners in Optometry, the
855-Oklahoma Board of Nursing, the State Board of Osteopathic Examiners
856-and the State Board of Veterinary Medical Examiners of t he top
857-twenty prescribers of controlled dangerous substances within their
858-respective areas of jurisdiction. Upon discovering that a
859-registrant is prescribing outside the limitations of his or her
860-licensure or outside of drug registr ation rules or applicab le state
861-laws, the respective licensing board sha ll be notified by the Bureau
862-in writing. Such notifications may be considered complaints for the
863-purpose of investigations or other actions by the respective
864-licensing board. Licensi ng boards shall have ex clusive jurisdiction
865-to take action against a lic ensee for a violation of subsection G of
866-this section.
867-J. Information regarding fatal and nonfatal overdoses, other
868-than statistical information as required by Section 2 -106 of this
869-title, shall be complete ly confidential. Access to this information
870-shall be strictly limited to the Director of the Oklahoma State
871-Bureau of Narcotics and Dangerous Drugs Control or designee, the
872-Chief Medical Examiner, state agencies and boards provided in
873-subsection A of this section, and the registrant that enters the
864+As used in this act:
865+1. “Board eligible” means successful completion of an
866+anesthesia, physical medicine and rehabilitation, rheumatology or
867+neurology residency program approved by the Accreditation Council
868+for Graduate Medical Education or the American Osteopathic
869+Association for a period of six (6) years from successful completion
870+of such residency program;
871+2. “Chronic nonmalignant pain” means pain unrelated to cancer
872+which persists beyond the usual course of disease or the injury that
873+is the cause of the pain or more than ninety (90) calend ar days
874+after surgery; and
875+3. “Pain management clinic” or “clinic” means any publicly or
876+privately owned facility:
877+a. that advertises in any m edium for any type of pain
878+management services, or
879+b. where in any month a majority of patients are
880+prescribed opioids, benzodiazepines, barbiturates or
881+carisoprodol for the treatment of chronic nonm alignant
882+pain.
883+SECTION 8. NEW LAW A new section of law to be codified
884+in the Oklahoma Statutes as Section 2 -1102 of Title 63, unless there
885+is created a duplication in numbering, reads as f ollows:
886+A. Each pain management clinic shall register with the State
887+Board of Medical Licensure and Supervision unless:
874888
875-Req. No. 3952 Page 18 1
889+ENGR. S. B. NO. 888 Page 3 1
876890 2
877891 3
878892 4
879893 5
880894 6
881895 7
882896 8
883897 9
884898 10
885899 11
886900 12
887901 13
888902 14
889903 15
890904 16
891905 17
892906 18
893907 19
894908 20
895909 21
896910 22
897911 23
898912 24
899913
900-information. Registrants shall not be liable to any person for a
901-claim of damages for information reported pursuant to the provisions
902-of Section 2-105 of this title.
903-K. The Director of t he Oklahoma State Burea u of Narcotics and
904-Dangerous Drugs Control shall provide adequate means and procedures
905-allowing access to central repository information for registrants
906-lacking direct computer access.
907-L. Upon completion of an investigation in which it is
908-determined that a death was caused by an overdose, either
909-intentionally or unintentionally, of a controlled dangerous
910-substance, the medical examiner shall be required to report the
911-decedent’s name and date of birth to the Oklahoma State Bureau of
912-Narcotics and Dangerous Drugs Control. The Oklahoma State Bureau of
913-Narcotics and Dangerous Drugs Control shall be required to maintain
914-a database containing the classification of medical practitioners
915-who prescribed or authorized controlled dangerous subs tances
916-pursuant to this subsection.
917-M. The Oklahoma State Bureau of Nar cotics and Dangerous Drugs
918-Control is authorized to provide unsolicited notification to the
919-licensing board of a pharmacist or practitioner if a patient has
920-received one or more prescriptions for controlled substances in
921-quantities or with a frequency inco nsistent with generally
922-recognized standards of safe practice. An unsolicited notification
923-to the licensing board of the practitioner pursuant to this section:
914+1. The majority of the physicians who provide services in the
915+clinic primarily provide s urgical services;
916+2. The clinic is owned by a publicly held corporation whose
917+shares are traded on a national exchange or on the over -the-counter
918+market and whose total assets at the end of the corporation ’s most
919+recent fiscal quarter exceeded Fifty Milli on Dollars
920+($50,000,000.00);
921+3. The clinic is affiliated with an accredited medical schoo l
922+at which training is provided for medical students, res idents or
923+fellows;
924+4. The clinic does not prescribe controlled dangerous
925+substances for the treatment of pai n;
926+5. The clinic is owned by a corporate enti ty exempt from
927+federal taxation under 26 U.S .C., Section 501(c)(3) (1954);
928+6. The clinic is wholly o wned and operated by one or more
929+board-eligible or board-certified anesthesiologists, physiatrists,
930+rheumatologists or neurologists; or
931+7. The clinic is wholly owned and operated by a physician
932+multispecialty practice where one or more board -eligible or board-
933+certified medical specialists, who have also completed fellowships
934+in pain medicine approved by the Accr editation Council for Graduate
935+Medical Education or who are also certified in pain medicin e by the
936+American Board of Pain Medicine or a board appro ved by the American
937+Board of Medical Specialties, the American Association of Physician
924938
925-Req. No. 3952 Page 19 1
939+ENGR. S. B. NO. 888 Page 4 1
926940 2
927941 3
928942 4
929943 5
930944 6
931945 7
932946 8
933947 9
934948 10
935949 11
936950 12
937951 13
938952 14
939953 15
940954 16
941955 17
942956 18
943957 19
944958 20
945959 21
946960 22
947961 23
948962 24
949963
950-1. Is confidential;
951-2. May not disclose info rmation that is confidential pursuant
952-to this section; and
953-3. May be in a summary form sufficient to provide notice of the
954-basis for the unsolicited notification.
955-N. Except as otherwise provided for in subsections A and B of
956-this section, any information collected at the central repository,
957-as outlined in Section 2-309C of this title, shall:
958-1. Be confidential by law and privileged;
959-2. Not be subject to the Oklahoma Open Records Act;
960-3. Not be subject to subpoena; and
961-4. Not be subject to discovery or admissible in evidence in any
962-private civil action.
963-O. Beginning January 1, 2024, upon receipt of a report from the
964-Chief Medical Examiner in which the cause of death or a contributing
965-factor to the death was determined to be one or more opioid drugs as
966-described in subsection B of Section 9 42 of this title, the Oklahoma
967-State Bureau of Narcotics and Dangerous Drugs Control shall search
968-the decedent in the central repository to determine if the decedent
969-had been prescribed one or more opioid drugs at any point in the
970-year prior to the death. Beginning January 1, 2024, if the Bureau
971-determines that the decedent had been prescribed one or more opioid
972-drugs at any point in the year prior to the death, the Bureau may
973-report the name of the prescribing practit ioner to the
964+Specialists or the Am erican Osteopathic Association, perform
965+interventional pain procedures of the type routine ly billed using
966+surgical codes.
967+B. Each clinic location shall be registered separately
968+regardless of whether the clinic is operated under the same business
969+name or management as another clinic.
970+C. As a part of registration, a clinic shall designate a
971+physician who is responsible for complying with all requirem ents
972+related to registration and operation of the clinic in compliance
973+with this act. Within ten (10) calend ar days after termination of a
974+designated physician, the clinic shall notify the State Board of
975+Medical Licensure and Supervision of the identity o f another
976+designated physician for that clinic. The designated physician
977+shall have a full, active and unenc umbered license pursuant to
978+Section 480 et seq. or Section 620 et seq. of Title 59 of the
979+Oklahoma Statutes and shall practice at the clinic locati on for
980+which the physician has assumed responsibility. Failing to have a
981+licensed designated physician pract icing at the location of the
982+registered clinic may be the basis for a summary suspension o f the
983+clinic registration certificate as described in thi s section.
984+D. The State Board of Medical Licensure and Supervision shall
985+deny registration to any clinic tha t is not fully owned by a
986+physician licensed p ursuant to Section 480 et seq. or Section 62 0 et
987+seq. of Title 59 of the Oklahoma Statutes or group o f physicians,
974988
975-Req. No. 3952 Page 20 1
989+ENGR. S. B. NO. 888 Page 5 1
976990 2
977991 3
978992 4
979993 5
980994 6
981995 7
982996 8
983997 9
984998 10
985999 11
9861000 12
9871001 13
9881002 14
9891003 15
9901004 16
9911005 17
9921006 18
9931007 19
9941008 20
9951009 21
9961010 22
9971011 23
9981012 24
9991013
1000-practitioner’s licensing board an d may report any other information
1001-from the central repository requested by the licensing board
1002-pertaining to the death for the purposes of investigation by the
1003-licensing board.
1004-SECTION 3. NEW LAW A new section of law to be codified
1005-in the Oklahoma Statutes as Section 2-312.3 of Title 63, unless
1006-there is created a duplica tion in numbering, reads as follows:
1007-Any licensed practitioner as defined in Section 353.1 of Title
1008-59 of the Oklahoma Statutes other than a veterinarian , or any health
1009-care provider other than a licensed practitioner, who has the
1010-authority to prescribe , dispense, or administer any controlled
1011-dangerous substance under Section 2-312 of Title 63 of the Oklahoma
1012-Statutes, or his or her employer on his or her behalf, shall carry
1013-malpractice insurance or demonstrate proof of financial
1014-responsibility in a minimum amount of One Million Dollars
1015-($1,000,000.00) per occurrence and Three Millio n Dollars
1016-($3,000,000.00) in the aggregate per year.
1017-SECTION 4. NEW LAW A new section of law to be codified
1018-in the Oklahoma Statutes as Section 2 -1102 of Title 63, unless there
1019-is created a duplication in numbering, reads as follows:
1020-As used in this act:
1021-1. "Chronic nonmalignant pain" means pain unrelated to cancer
1022-which persists beyond the usual course of disease or the injury that
1014+each of whom is licensed pursuant to Section 480 et seq. or Section
1015+620 et seq. of Title 59 of the Oklahoma Statutes.
1016+E. The State Board of Medical Licensure and Supervision shall
1017+deny registration to any pain management clinic owned by or w ith any
1018+contractual or employment relationship with a physician:
1019+1. Whose Drug Enforcement Administration nu mber has ever been
1020+revoked;
1021+2. Whose application for a license to prescribe, dispense or
1022+administer a controlled substance has been denied by any
1023+jurisdiction;
1024+3. Who has been convicted of or pleaded guilty or nolo
1025+contendere to, regardless of adjudicati on, an offense that
1026+constitutes a felony for r eceipt of illicit or diverted drugs,
1027+including a controlled substance listed in Schedule I, II, III, IV
1028+or V of the Uniform Controlled Dangerous Substances Act, in this
1029+state, any other state or the United Stat es.
1030+F. If the State Board of Medical Licensur e and Supervision
1031+finds that a pain management clinic does not meet the requirement of
1032+subsection D of this section or is owned, directly or indirectly, by
1033+a person meeting any criteria listed in subsection E o f this
1034+section, the State Board of Medical Lic ensure and Supervision shall
1035+revoke the certificate of registration previously issued by the
1036+State Board of Medical Licensure and Supervision. As determined by
1037+rule, the State Board of Medical Licensure and Supervision may grant
10231038
1024-Req. No. 3952 Page 21 1
1039+ENGR. S. B. NO. 888 Page 6 1
10251040 2
10261041 3
10271042 4
10281043 5
10291044 6
10301045 7
10311046 8
10321047 9
10331048 10
10341049 11
10351050 12
10361051 13
10371052 14
10381053 15
10391054 16
10401055 17
10411056 18
10421057 19
10431058 20
10441059 21
10451060 22
10461061 23
10471062 24
10481063
1049-is the cause of the pain or more than ninety (90) calendar days
1050-after surgery;
1051-2. “Licensed prescriber” means a licensed practitioner as
1052-defined in Section 353.1 of Title 59 of the Oklahoma Statutes other
1053-than a veterinarian, or any health care provider other than a
1054-licensed practitioner, who has the authority to prescribe any
1055-controlled dangerous s ubstance under Section 2 -312 of Title 63 of
1056-the Oklahoma Statutes; and
1057-3. "Pain management clinic" or "clinic" means any publicly or
1058-privately owned facility:
1059-a. that engages in significant paid advertising in any
1060-medium for any type of pain management services, and
1061-b. where in any month over sixty percent (60%) of
1062-patients who are not being seen for hospice or
1063-palliative care are prescribed opioids,
1064-benzodiazepines, barbiturates , or carisoprodol for the
1065-treatment of chronic nonmalignant pain.
1066-SECTION 5. NEW LAW A ne w section of law to be codified
1067-in the Oklahoma Statutes as Section 2-1103 of Title 63, unless there
1068-is created a duplication in numbering, reads as follows:
1069-A. Each pain management clinic shall register with the Oklahoma
1070-State Bureau of Narcotics and Dangerous Drugs Control unless:
1064+an exemption to denying a registration or revoking a previously
1065+issued registration if more than ten (10) years have elapsed si nce
1066+adjudication. As used in this section, the term “convicted”
1067+includes an adjudication of guilt following a plea of guilty or nolo
1068+contendere or the for feiture of a bond when charged with a crime.
1069+G. If the registration of a pain management clinic is revoked
1070+or suspended, the designated physician of the pain management
1071+clinic, the owner or lessor of the pain management clinic property,
1072+the manager and the proprietor shall cease to operate the faci lity
1073+as a pain management clinic as of the effective date of the
1074+suspension or revocation.
1075+H. If a pain management clinic registration is revoked or
1076+suspended, the designated physician of the pain management clinic,
1077+the owner or lessor of the clinic prope rty, the manager or the
1078+proprietor is responsible for rem oving all signs and symbols
1079+identifying the premises as a pain management clinic.
1080+I. If the clinic’s registration is revoked, any person named in
1081+the registration documents of the pain management clinic, including
1082+persons owning or operating the pain management clinic, shall not,
1083+as an individual or as a part of a group, apply to operate a pain
1084+management clinic for five (5) years after the date the registr ation
1085+is revoked.
10711086
1072-Req. No. 3952 Page 22 1
1087+ENGR. S. B. NO. 888 Page 7 1
10731088 2
10741089 3
10751090 4
10761091 5
10771092 6
10781093 7
10791094 8
10801095 9
10811096 10
10821097 11
10831098 12
10841099 13
10851100 14
10861101 15
10871102 16
10881103 17
10891104 18
10901105 19
10911106 20
10921107 21
10931108 22
10941109 23
10951110 24
10961111
1097-1. The clinic is affiliated wi th an accredited medical school
1098-at which training is provided for medical students, residents , or
1099-fellows;
1100-2. The clinic does not prescribe controlled dangerous
1101-substances for the treatment of pain;
1102-3. The clinic primarily treats hospice or palliative ca re
1103-patients; or
1104-4. A majority of the patients treated by the clinic are treated
1105-for acute pain.
1106-B. Each clinic location shall be registered separately
1107-regardless of whether the clinic is operated under the same business
1108-name or management as another cl inic and each clinic location shall
1109-be a permanent, fixed, physical address of operation .
1110-C. As a part of registration, a clinic shall designate a n owner
1111-or administrator who is responsible for ensuring compliance with all
1112-requirements related to registrati on and operation of the clinic
1113-under this act. Within ten (10) calendar days after terminati on of
1114-a designated administrator, the clinic shall notify the Bureau of
1115-the identity of another designated administrator for that clinic.
1116-Failing to have a designated administrator at the location of the
1117-registered clinic may be the basis for a summary suspension o f the
1118-clinic registration certificate as d escribed in this section.
1112+J. The period of suspensi on for the registration of a pain
1113+management clinic shall be prescribed by the State Board of Medical
1114+Licensure and Supervision but shall not exceed one (1) year.
1115+K. A change of ownership of a registered pain management clinic
1116+requires submission of a new registration application.
1117+SECTION 9. NEW LAW A new section of law to be codified
1118+in the Oklahoma Statutes as Section 2 -1103 of Title 63, unl ess there
1119+is created a duplication in numberin g, reads as follows:
1120+A. A physician shall no t practice medicine in a pain management
1121+clinic if the clinic is not registered with the State Board of
1122+Medical Licensure and Supervision as required by this act. Any
1123+physician who qualifies to practice medicin e in a pain management
1124+clinic pursuant to rul es adopted by the State Board of Medical
1125+Licensure and Supervision may continue to practice medicine in a
1126+pain management clinic as long as the physician continues to mee t
1127+the qualifications prescribed in the rules. A physician who
1128+violates this subsectio n is subject to disciplinary action by his or
1129+her appropriate medical regulatory board.
1130+B. Only a physician licensed pur suant to Section 480 et seq. or
1131+Section 620 et seq. of Title 59 of the Oklahoma Statutes m ay
1132+prescribe a controlled dangerous substance on the premises of a
1133+registered pain management clinic. No person shall dispense any
1134+controlled dangerous substance on the premises of a pain management
1135+clinic.
11191136
1120-Req. No. 3952 Page 23 1
1137+ENGR. S. B. NO. 888 Page 8 1
11211138 2
11221139 3
11231140 4
11241141 5
11251142 6
11261143 7
11271144 8
11281145 9
11291146 10
11301147 11
11311148 12
11321149 13
11331150 14
11341151 15
11351152 16
11361153 17
11371154 18
11381155 19
11391156 20
11401157 21
11411158 22
11421159 23
11431160 24
11441161
1145-D. The Bureau shall deny registration to any pain management
1146-clinic owned by or with any contractual or employment relationship
1147-with a licensed prescriber:
1148-1. Whose Drug Enforcement Administration number has ever been
1149-revoked;
1150-2. Whose application for a license to prescribe, dispense , or
1151-administer a controlled substance has been denied for disciplinary
1152-action by the appropriate licensing board; or
1153-3. Who has been convicted of or pleaded guilty or nolo
1154-contendere to, regardless of adjudication, an offense that
1155-constitutes a felony for receipt of illicit or diverted drugs
1156-including a controlled substance listed in Sc hedule I, II, III, IV,
1157-or V of the Uniform Controlled Dangerous Substances Act, in this
1158-state, any other state , or the United States.
1159-E. If the Bureau finds that a pain management clinic is owned,
1160-directly or indirectly, by a person meeting any criteria listed in
1161-subsection D of this section, the Bureau shall revoke the
1162-certificate of registration previously iss ued by the Bureau. As
1163-determined by rule, the Bureau may grant an exemption to denying a
1164-registration or revoking a previously issued registration if more
1165-than five (5) years have elapsed since adjudication. As used in
1166-this section, the term "convicted" includes an adjudication of guilt
1167-following a plea of guilty or nolo contendere or the forfeiture of a
1168-bond when charged with a crime.
1162+C. A physician, a physician assistant or an Advanced Practice
1163+Registered Nurse shall perform a physical examination of a patient
1164+on the same day that the physician prescribes a controlled substance
1165+to a patient at a pain management clinic. If the physician
1166+prescribes more than a seventy -two-hour dose of controlled dangerous
1167+substances for the treatment of chronic nonmalignant pain, the
1168+physician shall document in the patient’s record the reason for
1169+prescribing that quantity.
1170+D. A physician authorized to prescri be controlled dangerous
1171+substances who practices at a pain management clinic is responsible
1172+for maintaining the control and security of his or her prescription
1173+blanks and any other method used for prescribing controlled
1174+dangerous substance pain medication. The physician shall notify, in
1175+writing, the State Board of Medical Licensure and Supervision within
1176+twenty-four (24) hours following any thef t or loss of a prescription
1177+blank or breach of any other method for prescribing pain medication.
1178+E. The designated physician of a pain management clinic shall
1179+notify the applicable board in writing of the date of termination of
1180+employment within ten (10) calendar days after terminating his or
1181+her employment with a pain management clinic that is required to be
1182+registered pursuant to this act. Each physicia n practicing in a
1183+pain management clinic shall advise the State Board of Medical
1184+Licensure and Supervision, in writing, within ten (10) calendar days
11691185
1170-Req. No. 3952 Page 24 1
1186+ENGR. S. B. NO. 888 Page 9 1
11711187 2
11721188 3
11731189 4
11741190 5
11751191 6
11761192 7
11771193 8
11781194 9
11791195 10
11801196 11
11811197 12
11821198 13
11831199 14
11841200 15
11851201 16
11861202 17
11871203 18
11881204 19
11891205 20
11901206 21
11911207 22
11921208 23
11931209 24
11941210
1195-F. If the registration of a pain man agement clinic is revoked
1196-or suspended, the designated administrator of the pain management
1197-clinic, the owner or lessor of the pain management clinic property,
1198-the manager, and the proprietor shall cea se to operate the facility
1199-as a pain management clinic as of the effective date of the
1200-suspension or revocation.
1201-G. If a pain management clinic registration is revoked or
1202-suspended, the designated administrator of the pain management
1203-clinic, the owner or lessor of the clinic property, the manager , or
1204-the proprietor is responsible for removing all signs and symbols
1205-identifying the premises as a pain management clinic.
1206-H. If the clinic's registration is revoked, any person named in
1207-the registration document s of the pain management clinic including
1208-persons owning or oper ating the pain management clinic, s hall not,
1209-as an individual or as a part of a group, apply to operate a pain
1210-management clinic for one (1) year after the date the registration
1211-is revoked.
1212-I. The period of suspension for the registration of a pain
1213-management clinic shall be prescribed by the Bureau but shall not
1214-exceed one (1) year.
1215-J. A change of ownership of a registered pain management clinic
1216-shall require submission of a new registration application.
1211+after beginning or ending his or her practice at a pain management
1212+clinic.
1213+F. Each physician practicing i n a pain management clinic is
1214+responsible for ensuring compliance with the following facility and
1215+physical operations requirements:
1216+1. A pain management clinic shall be located and operated at a
1217+publicly accessible fixed location and shall:
1218+a. display a sign that can be viewed by t he public that
1219+contains the clinic name, hours of operation s and a
1220+street address,
1221+b. have a publicly listed telephone number and a
1222+dedicated phone number to send and receive facsimiles
1223+with a facsimile machine that shall be ope rational
1224+twenty-four (24) hours per day,
1225+c. have emergency lighting and communications,
1226+d. have a reception and waiting area,
1227+e. provide a restroom,
1228+f. have an administrative area, including room for
1229+storage of medical records, supplies and equipment,
1230+g. have private patient examina tion rooms,
1231+h. have treatment rooms, if treatment is being provided
1232+to the patients, and
1233+i. display a printed sign located in a conspicuous place
1234+in the waiting room viewable by the public with the
12171235
1218-Req. No. 3952 Page 25 1
1236+ENGR. S. B. NO. 888 Page 10 1
12191237 2
12201238 3
12211239 4
12221240 5
12231241 6
12241242 7
12251243 8
12261244 9
12271245 10
12281246 11
12291247 12
12301248 13
12311249 14
12321250 15
12331251 16
12341252 17
12351253 18
12361254 19
12371255 20
12381256 21
12391257 22
12401258 23
12411259 24
12421260
1243-SECTION 6. NEW LAW A new section of law to be codified
1244-in the Oklahoma Statutes as Section 2-1104 of Title 63, unless there
1245-is created a duplication in numbering, reads as follows:
1246-A. A licensed prescriber shall not be employed or contracted by
1247-or otherwise practice i n a pain management clinic if the clinic is
1248-not licensed by the Oklahoma State Bureau of Narcotics and Dangerous
1249-Drugs Control under this act and registered with the Bureau under
1250-Section 2-301 et seq. of Title 63 of the Oklahoma Statutes. A
1251-licensed prescriber who qualifies to practice in a pain management
1252-clinic pursuant to rules adopted by the appropriate licensing board
1253-may continue to practice in a pain management clinic as long as the
1254-licensed prescriber continues to meet the qualifications prescribed
1255-in the rules. A licensed prescriber who violates this subsection is
1256-subject to disciplinary action by the appropriate licensing board.
1257-B. Only a licensed prescriber licensed in this state and
1258-authorized to prescribe controlled dangerous substances under
1259-Section 2-312 of Title 63 of the Oklahoma Statutes may prescribe a
1260-controlled dangerous subst ance on the premises of a reg istered pain
1261-management clinic and only to the extent allowed by Section 2-312 of
1262-Title 63 of the Oklahoma Statutes . No person shall dispense any
1263-controlled dangerous substance on the premises of a pain m anagement
1264-clinic. The provisions of this subsection shall not be construed to
1265-expand or otherwise modify the prescriptive authority of any
1266-licensed prescriber.
1261+name and contact information of the clinic’s
1262+designated physician and the names of all physicians
1263+practicing in the clinic; and
1264+2. This section does not excuse a physician from providing any
1265+treatment or performing any medical duty without the pr oper
1266+equipment and materials as required by the standard of care. This
1267+section does not supersede the level of care, skill or treatment
1268+recognized in general law related to health care licensure.
1269+G. Each physician practicing in a pain management clinic is
1270+responsible for ensuring compliance wi th the following infection
1271+control requirements:
1272+1. The clinic shall maintain equipment and supplies t o support
1273+infection prevention and control activities;
1274+2. The clinic shall identify infection risks based on the
1275+following:
1276+a. geographic location, comm unity and population served ,
1277+b. the care, treatment and services it provides, and
1278+c. an analysis of its infection surveillance and control
1279+data; and
1280+3. The clinic shall maintain written infection prevention
1281+policies and procedures that address the followi ng:
1282+a. prioritized risks,
1283+b. limiting unprotected exposure to pathogens,
12671284
1268-Req. No. 3952 Page 26 1
1285+ENGR. S. B. NO. 888 Page 11 1
12691286 2
12701287 3
12711288 4
12721289 5
12731290 6
12741291 7
12751292 8
12761293 9
12771294 10
12781295 11
12791296 12
12801297 13
12811298 14
12821299 15
12831300 16
12841301 17
12851302 18
12861303 19
12871304 20
12881305 21
12891306 22
12901307 23
12911308 24
12921309
1293-C. A licensed prescriber shall perform a physical examinatio n
1294-of a patient on the same day that t he licensed prescriber prescribes
1295-a controlled substance to a patient at a pain management clin ic.
1296-D. A licensed prescriber authorized to prescribe controlled
1297-dangerous substances who practices at a pain management clinic is
1298-responsible for maintaining the control and securi ty of his or her
1299-prescription blanks and an y other method used for prescribing
1300-controlled dangerous substance pain medication. The licensed
1301-prescriber shall notify, in writing, the Bureau within twenty-four
1302-(24) hours following any theft or loss of a prescription bl ank or
1303-breach of any other method for prescribing pain medication. The
1304-provisions of this subsection shall not be construed to exempt a
1305-licensed prescriber from any electronic prescription requirements
1306-stipulated in Section 2-309 of Title 63 of the Oklahoma Statutes.
1307-E. The designated administrator of a pain management clinic
1308-shall notify the Bureau in writing of the date of termination of
1309-employment within ten (10) calendar days after terminatin g his or
1310-her employment with a pain manage ment clinic that is required to be
1311-registered pursuant to this act .
1312-F. The owners of a pain management clinic are jointly
1313-responsible for ensuring compliance with the following faci lity and
1314-physical operations requirements:
1315-1. A pain management clinic shall be located and operated at a
1316-publicly accessible fixed location and shall:
1310+c. limiting the transmission o f infections associated
1311+with procedures performed in the clinic, and
1312+d. limiting the transmission of infections a ssociated
1313+with the clinic’s use of medical equipment, devices
1314+and supplies.
1315+H. Each physician practicing in a pain management clinic is
1316+responsible for ensuring compliance with the following health and
1317+safety requirements:
1318+1. The clinic, including its gr ounds, buildings, furniture,
1319+appliances and equipment shall be str ucturally sound, in good
1320+repair, clean and free from health and safety hazard s;
1321+2. The clinic shall have evacuation procedures in the event of
1322+an emergency, which shall include provisions f or the evacuation of
1323+disabled patients and employees;
1324+3. The clinic shall have a writ ten facility-specific disaster
1325+plan specifying actions that will be taken in the event of clinic
1326+closure due to unforeseen disasters and shall include provisions for
1327+the protection of medical records; and
1328+4. Each clinic shall have at l east one employee on the premises
1329+during patient care hours who is certified in basic life support and
1330+is trained in reacting to accidents and medical emergencies until
1331+emergency medical per sonnel arrive.
1332+I. The designated physic ian is responsible for ens uring
1333+compliance with the following quality assurance requirements:
13171334
1318-Req. No. 3952 Page 27 1
1335+ENGR. S. B. NO. 888 Page 12 1
13191336 2
13201337 3
13211338 4
13221339 5
13231340 6
13241341 7
13251342 8
13261343 9
13271344 10
13281345 11
13291346 12
13301347 13
13311348 14
13321349 15
13331350 16
13341351 17
13351352 18
13361353 19
13371354 20
13381355 21
13391356 22
13401357 23
13411358 24
13421359
1343-a. display a sign that can be viewed b y the public that
1344-contains the clinic name, hours of operations , and a
1345-street address,
1346-b. have a publicly listed telephone number and a
1347-dedicated phone number to send and receive facsimiles,
1348-c. have a reception and waiting area,
1349-d. provide a restroom,
1350-e. have private patient examination rooms,
1351-f. have treatment rooms, i f treatment is being provided
1352-to the patients, and
1353-g. display a printed sign loc ated in a conspicuous place
1354-in the waiting room viewable by the public with the
1355-name and contact information of the clinic's
1356-designated administrator and the names of all licensed
1357-prescribers practicing in the clinic; and
1358-2. This section does not excuse a licensed prescriber from
1359-providing any treatment or performing any medical duty without the
1360-proper equipment and materials as required by the standard of care.
1361-This section does not supersede the le vel of care, skill, or
1362-treatment recognized in general law related to health care
1363-licensure.
1364-G. Each owner or designated administrator of a pain management
1365-clinic is responsible for ensuring compliance with infection
1360+1. Each pain management clinic shall have an ongoing quality
1361+assurance program that objectively and systematically:
1362+a. monitors and evaluates the quality and app ropriateness
1363+of patient care,
1364+b. evaluates methods to improve patient care,
1365+c. identifies and corrects deficiencies within the
1366+facility,
1367+d. alerts the designated physician to identify and
1368+resolve recurring problems, and
1369+e. provides for opportunities to imp rove the facility’s
1370+performance and to enhance and improve the quality of
1371+care provided to the public; and
1372+2. The designated physician shall establish a quality assurance
1373+program that includes the following componen ts:
1374+a. the identification, investigation and analysis of the
1375+frequency and causes of a dverse incidents to patients,
1376+b. the identification of tr ends or patterns of incidents,
1377+c. the development of measures to correct, reduce,
1378+minimize or eliminate the risk of adverse incidents to
1379+patients, and
1380+d. the documentation of thes e functions and peri odic
1381+review no less than quarterly of such information by
1382+the designated physician.
13661383
1367-Req. No. 3952 Page 28 1
1384+ENGR. S. B. NO. 888 Page 13 1
13681385 2
13691386 3
13701387 4
13711388 5
13721389 6
13731390 7
13741391 8
13751392 9
13761393 10
13771394 11
13781395 12
13791396 13
13801397 14
13811398 15
13821399 16
13831400 17
13841401 18
13851402 19
13861403 20
13871404 21
13881405 22
13891406 23
13901407 24
13911408
1392-prevention and control requirements stipulated by the Occupational
1393-Safety and Health Administration.
1394-H. The designated administrator shall establish a quality
1395-assurance program that includes the identification, investigation,
1396-and analysis of the frequency and causes of adverse incidents to
1397-patients. The designated administrator is responsible for ensuring
1398-compliance with the quality assurance requirements.
1399-I. The designated administrator is responsible for ensuring
1409+J. The designated physician is responsible for ensuring
14001410 compliance with the following data collection and reporting
14011411 requirements:
1402-1. The designated administrator for each pain management clinic
1403-shall report all significant adverse incidents to the Bureau; and
1404-2. The designated administrator shall also report to the
1405-Bureau, in writing, on a quarterly basis the following data:
1412+1. The designated ph ysician for each pain management clinic
1413+shall report all adverse incidents to the State Board of Medical
1414+Licensure and Supervision; and
1415+2. The designated physician shall also report to the State
1416+Board of Medical Licensure and Supervision, in writing, on a
1417+quarterly basis the following data:
14061418 a. the number of new and repeat patients seen and treated
14071419 at the clinic who are prescribed controlled dangerous
14081420 substance medications for the treatment o f chronic,
14091421 nonmalignant pain,
1410-b. the number of patients diagnosed with substance use
1411-disorder,
1422+b. the number of patients discharged due to drug abuse,
14121423 c. the number of patients discharged due to drug
14131424 diversion, and
14141425 d. the number of patients treated at the clinic whose
14151426 domicile is located somewhere other than in this
1427+state. A patient’s domicile is the patient ’s fixed or
1428+permanent home to which he or she intends to return
1429+even though he or she may temporarily r eside
1430+elsewhere.
14161431
1417-Req. No. 3952 Page 29 1
1432+ENGR. S. B. NO. 888 Page 14 1
14181433 2
14191434 3
14201435 4
14211436 5
14221437 6
14231438 7
14241439 8
14251440 9
14261441 10
14271442 11
14281443 12
14291444 13
14301445 14
14311446 15
14321447 16
14331448 17
14341449 18
14351450 19
14361451 20
14371452 21
14381453 22
14391454 23
14401455 24
14411456
1442-state. A patient's domicile is the patient's fixed or
1443-permanent home to which he or she intends to return
1444-even though he or she may temporarily reside
1445-elsewhere.
1446-J. The data and reports specified in subsection I of this
1447-section shall be accessible to each appropriate licensing board.
1448-K. Each pain management clin ic shall establish a written policy
1449-and administrative process for transferring care of patients
1450-diagnosed with a substance use disorder where appropriate for their
1451-continued treatment. Each appropriate licensing board shall issue
1452-guidance on best practices to ensure appropriate referral and
1453-treatment of patients with a substance use disorder.
1454-L. Upon referral by the ap propriate licensing board, the Bureau
1455-shall investigate suspected instances of drug diversion involving a
1456-pain management clinic. Nothing in this act shall be construed to
1457-restrict the appropriate licensing board from conducting its own
1458-investigation into instances of suspected drug diversion.
1459-SECTION 7. NEW LAW A new sectio n of law to be codified
1460-in the Oklahoma Statutes as Section 2-1105 of Title 63, unless there
1457+SECTION 10. NEW LAW A new section of law to be codified
1458+in the Oklahoma Statutes as Section 2 -1104 of Title 63, unless there
14611459 is created a duplication in number ing, reads as follows:
1462-A. The Oklahoma State Bureau of Narcotics and Dangerous Drugs
1463-Control may impose an administrative fine on a clinic of up to One
1464-Thousand Dollars ($1,000.00) per violation for violating the
1460+A. The State Board of Medical Lic ensure and Supervision may
1461+impose an administrative fine on a clinic of up to Five Thousand
1462+Dollars ($5,000.00) p er violation for violating the requireme nts of
1463+this act or the rules of the State Board of Medical Licensure and
1464+Supervision. In determining w hether a penalty is to be imposed, and
1465+in fixing the amount of the fine, the State Board of Medical
1466+Licensure and Supervision shall consider the followin g factors:
1467+1. The gravity of the violation, i ncluding the probability that
1468+death or serious physical o r emotional harm to a patient has
1469+resulted, or could have resulted, from the pain management clinic’s
1470+actions or the actions of the physician, the severi ty of the action
1471+or potential harm and the ext ent to which the provisions of the
1472+applicable laws or rul es were violated;
1473+2. What actions, if any, the owner or designated physician took
1474+to correct the violations;
1475+3. Whether there were any previous violati ons at the pain
1476+management clinic; and
1477+4. The financial benefits that the pain management clinic
1478+derived from committing or continuing to commit the violation.
1479+B. Each day a violation continues after the date fixed for
1480+termination of the violation as ord ered by the State Board of
14651481
1466-Req. No. 3952 Page 30 1
1482+ENGR. S. B. NO. 888 Page 15 1
14671483 2
14681484 3
14691485 4
14701486 5
14711487 6
14721488 7
14731489 8
14741490 9
14751491 10
14761492 11
14771493 12
14781494 13
14791495 14
14801496 15
14811497 16
14821498 17
14831499 18
14841500 19
14851501 20
14861502 21
14871503 22
14881504 23
14891505 24
14901506
1491-requirements of this act or the rules promulgated by the Bureau to
1492-enforce this act.
1493-B. Each day a violation continues after the date fixed for
1494-termination of the violati on as ordered by the Bureau constitutes an
1495-additional, separate, and distinct violation.
1496-C. The Bureau may impose a fine and, in the case of an owner -
1497-operated pain management clinic, revoke or deny a pain management
1498-clinic's registration if the clinic's owner or designated
1499-administrator knowingly and intentionally misrepresents actions
1500-taken to correct a violation.
1501-D. An owner or designated administrator of a pain management
1502-clinic who concurren tly operates an unregistered pain management
1503-clinic is subject to an administrative fine of One Thousand Dollars
1504-($1,000.00) per day.
1507+Medical Licensure and Supervision constitutes an additional,
1508+separate and distinct violation.
1509+C. The State Board of Medical Licensure and Supervision may
1510+impose a fine and, in the case of an owner-operated pain management
1511+clinic, revoke or deny a pain management clinic’s registration if
1512+the clinic’s designated physician knowingly and intentionally
1513+misrepresents actions taken to correct a violation.
1514+D. An owner or designated physician of a pain management clinic
1515+who concurrently operates an unregistered pain management clinic is
1516+subject to an administrative fine of Five Thousand D ollars
1517+($5,000.00) per day.
15051518 E. If the owner of a pain management clinic that requires
15061519 registration fails to appl y to register the clinic upon a change of
15071520 ownership and operates the clinic under the new ownership, the owner
1508-is subject to a fine of One Thousand Dollars ($1,000.00).
1509-SECTION 8. NEW LAW A n ew section of law to be codified
1510-in the Oklahoma Statutes as Section 2 -1106 of Title 63, unless there
1521+is subject to a fine of Five Tho usand Dollars ($5,000.00).
1522+SECTION 11. NEW LAW A new section of law to be codified
1523+in the Oklahoma Statutes as Section 2 -1105 of Title 63, unless there
15111524 is created a duplication in numbering, reads as follows:
1512-The Oklahoma State Bureau of Narcotics and Dangerous Drugs
1513-Control and all appropriate licensing boards shall promulgate such
1514-rules as are necessary to implement the pr ovisions of this act.
1525+All affected agencies an d boards shall promulgate such rules as
1526+are necessary to implement the provisions of this act .
1527+SECTION 12. AMENDATORY 59 O.S. 2 011, Section 355.1, as
1528+amended by Section 21, C hapter 230, O.S.L. 2015 (59 O.S. Supp. 2020,
1529+Section 355.1), is amended to read as follows:
15151530
1516-Req. No. 3952 Page 31 1
1531+ENGR. S. B. NO. 888 Page 16 1
15171532 2
15181533 3
15191534 4
15201535 5
15211536 6
15221537 7
15231538 8
15241539 9
15251540 10
15261541 11
15271542 12
15281543 13
15291544 14
15301545 15
15311546 16
15321547 17
15331548 18
15341549 19
15351550 20
15361551 21
15371552 22
15381553 23
15391554 24
15401555
1541-SECTION 9. AMENDATORY 63 O.S. 2021, Section 942, is
1542-amended to read as follows:
1543-Section 942. A. 1. Upon completion of an investigation, the
1544-medical examiner shall reduce his or h er findings to writing upon
1545-the form supplied to the medical examiner which shall be promptly
1546-sent to the Chief Medical Examiner by mail.
1547-2. If the medical examiner finds that the deceased had illicit,
1548-prescription or nonprescription drugs in his or her s ystem at the
1549-time of death, the medical examiner shall document in his or her
1550-findings if the death was:
1551-a. a natural or accidental death with drug involvement,
1552-b. a homicide by drugs,
1553-c. a suicide by drug overdose, or
1554-d. a death with drug involvement, but the manner of death
1555-could not be determined.
1556-3. A fatality shall not be considered a drug -related death
1557-unless the medical examiner dete rmines that the drug or drugs
1558-present in the deceased materially contributed to the death.
1559-B. Copies of reports shall be furnished by the Chief Medical
1560-Examiner to investigating agencies having official interest therein.
1561-Copies of reports shall also be f urnished to the spouse of the
1562-deceased or any person within one degree of consanguinity of the
1563-deceased upon request a nd within five (5) business days of the
1564-request once the cause and manner of death have been de termined and
1556+Section 355.1. A. Except as provided for in Section 353.1 et
1557+seq. of this title, only a licensed practitioner may d ispense
1558+dangerous drugs to such practitioner ’s patients, and only for the
1559+expressed purpose of serving t he best interests and promoting the
1560+welfare of such patients. The dangerous drugs shall be dispensed in
1561+an appropriate container to which a label has b een affixed. Such
1562+label shall include the name and office address of the licensed
1563+practitioner, date di spensed, name of patient, directions for
1564+administration, prescription number, the trade or generic name and
1565+the quantity and strength, not meaning ingre dients, of the drug
1566+therein contained; provided , this requirement shall not apply to
1567+compounded medicines. The licensed practitioner shall keep a
1568+suitable book, file or record in which shall be preserved for a
1569+period of not less than five (5) years a reco rd of every dangerous
1570+drug compounded or dispen sed by the licensed practitioner.
1571+B. A prescriber desiring to dispense dangerous drugs pursuant
1572+to this section shall register annually with the appropriate
1573+licensing board as a dispenser, through a regulator y procedure
1574+adopted and prescribed by such lice nsing board.
1575+C. A prescriber who dispenses professional samples to patients
1576+shall be exempt from the requirement of subsection B of this section
1577+if:
1578+1. The prescriber f urnishes the professional samples to th e
1579+patient in the package provided by the manufa cturer;
15651580
1566-Req. No. 3952 Page 32 1
1581+ENGR. S. B. NO. 888 Page 17 1
15671582 2
15681583 3
15691584 4
15701585 5
15711586 6
15721587 7
15731588 8
15741589 9
15751590 10
15761591 11
15771592 12
15781593 13
15791594 14
15801595 15
15811596 16
15821597 17
15831598 18
15841599 19
15851600 20
15861601 21
15871602 22
15881603 23
15891604 24
15901605
1591-the death certificate has been issued. Beginning January 1, 2024,
1592-the Chief Medical Examiner shall furnish a copy of any report in
1593-which the cause of death or a contributing factor to the death was
1594-determined to be one or more opioid drugs to the Oklahoma State
1595-Bureau of Narcotics and Dangerous Drugs Control for the purpose of
1596-implementing the provisions of subsection O of Section 2-309D of
1597-this title.
1598-SECTION 10. This act shall become effective November 1, 2022.
1606+2. No charge is made to the patient; and
1607+3. An appropriate record is entered in the patient ’s chart.
1608+D. This section shall not apply to the services provided
1609+through the State Department of Health, city/county health
1610+departments, or the Department of Mental Health and Substance Abuse
1611+Services.
1612+E. This section shall not apply to organizations and services
1613+incorporated as state or federal tax -exempt charitable no nprofit
1614+entities and/or organizations a nd services receiving all or part of
1615+their operating funds from a local, state or federal governmental
1616+entity; provided, such organizations and services shall comply with
1617+the labeling and recordkeeping requirements se t out in subsection A
1618+of this section.
1619+F. A prescriber who issues a prescription for a controlled
1620+dangerous substance shall not dispense the controlled dangerous
1621+substance pursuant to such prescription. A prescriber shall not
1622+dispense a controlled danger ous substance pursuant to a prescriptio n
1623+issued by another prescriber if the dispensin g prescriber has a
1624+financial interest in the practice of the prescribing prescriber.
1625+The restrictions on dispensing of controlled dangerous substances
1626+provided by this subsection shall not apply to substance abuse
1627+treatment programs or services.
1628+SECTION 13. This act shall become effective Novemb er 1, 2021.
15991629
1600-58-2-3952 DC 5/20/2022 11:06:15 AM
1630+ENGR. S. B. NO. 888 Page 18 1
1631+2
1632+3
1633+4
1634+5
1635+6
1636+7
1637+8
1638+9
1639+10
1640+11
1641+12
1642+13
1643+14
1644+15
1645+16
1646+17
1647+18
1648+19
1649+20
1650+21
1651+22
1652+23
1653+24
1654+
1655+Passed the Senate the 10th day of March, 2021.
1656+
1657+
1658+
1659+ Presiding Officer of the Senate
1660+
1661+
1662+Passed the House of Representatives the ____ day of __________,
1663+2021.
1664+
1665+
1666+
1667+ Presiding Officer of the House
1668+ of Representatives
1669+
1670+